Mesa Laboratories, Inc.
MLAB
$125.85
$3.522.88%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 237.75M | 228.38M | 223.71M | 216.19M | 212.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 237.75M | 228.38M | 223.71M | 216.19M | 212.87M |
| Cost of Revenue | 86.68M | 83.67M | 82.80M | 82.12M | 82.98M |
| Gross Profit | 151.06M | 144.71M | 140.91M | 134.07M | 129.90M |
| SG&A Expenses | 112.55M | 112.80M | 112.67M | 112.77M | 111.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 218.86M | 215.34M | 214.69M | 214.19M | 213.15M |
| Operating Income | 18.89M | 13.04M | 9.02M | 2.00M | -274.00K |
| Income Before Tax | -269.83M | -265.67M | -270.81M | -275.65M | -593.00K |
| Income Tax Expenses | -20.39M | -20.02M | -20.50M | -21.40M | -1.54M |
| Earnings from Continuing Operations | -249.44 | -245.65 | -250.31 | -254.25 | 0.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -249.44M | -245.65M | -250.31M | -254.25M | 948.00K |
| EBIT | 18.89M | 13.04M | 9.02M | 2.00M | -274.00K |
| EBITDA | 42.22M | 39.92M | 37.93M | 33.57M | 33.37M |
| EPS Basic | -46.25 | -45.54 | -46.41 | -47.14 | 0.18 |
| Normalized Basic EPS | 0.26 | 0.74 | 0.10 | -0.18 | -0.07 |
| EPS Diluted | -46.26 | -45.56 | -46.42 | -47.14 | 0.17 |
| Normalized Diluted EPS | 0.26 | 0.74 | 0.10 | -0.18 | -0.07 |
| Average Basic Shares Outstanding | 21.63M | 21.60M | 21.57M | 21.55M | 21.50M |
| Average Diluted Shares Outstanding | 21.72M | 21.69M | 21.60M | 21.55M | 21.54M |
| Dividend Per Share | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Payout Ratio | -1.39% | -1.41% | -1.38% | -1.36% | 362.76% |
